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2 Strategic Activity Development, Karolinska
University Hospital, Stockholm, Sweden
Abstract
Background: Haemolysis is usually caused by inade-
quate specimen collection or preanalytical handling,
and is suggested to be a suitable indicator of pre-
analytical quality. We investigated the prevalence of
detectable haemolysis in all routine venous blood
samples to identify differences in preanalytical
quality.
Methods: Haemolysis index (HI) values were obtained
from a Vitros 5,1 in the routine clinical chemistry lab-
oratory for samples collected in primary health care
centres (PHCs), nursing homes, and a hospital emer-
gency department (ED). Haemolysis was defined as a
HI G15 (detection limit).
Results: Samples from the PHC with the highest pre-
valence of haemolysis were 6.1 times (95% confi-
dence interval (CI) 4.0–9.2) more often haemolysed
compared to the centre with the lowest prevalence. Of
the samples collected in primary health care, 10.4%
were haemolysed compared to 31.1% in the ED (p-
0.001). A notable difference in haemolysed samples
was found between the ED section staffed by emer-
gency medicine physicians and the section staffed by
primary health care physicians (34.8% vs. 11.3%,
p-0.001).
Conclusions: The significant variation in haemolysis
indices among the investigated units is likely to reflect
varying preanalytical conditions. The HI is a valuable
tool for estimation and follow-up of preanalytical
quality in primary health care.
Clin Chem Lab Med 2009;47:940–4.
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Introduction
Haemolysis is the release of haemoglobin and other
intracellular components from erythrocytes into the
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surrounding plasma following damage of the cell
membrane (1). Haemolysis is a common reason for
specimen rejection (2), reported to account for
40%–70% of all unsuitable specimens sent to the lab-
oratory (1). The variation is dependent on different
methods used for estimation of haemolysis, as well
as different cut-off thresholds for analytical interfer-
ence. A growing body of evidence indicates that most
errors in laboratory testing arise in the preanalytical
phase (3, 4) as the result of human mistakes (5). In
vitro haemolysis is one important example since this
is caused primarily by inappropriate specimen collec-
tion and handling (1), such as prolonged use of
venous stasis (6), delayed separation of blood from
plasma (1) and blood collection through intravenous
catheters (7, 8).
We have previously reported unsatisfactory blood
collection practices in primary health care centres
(PHCs) (9, 10), where the majority of patient contact
with caregivers occurs (11). This emphasises the
importance of the preanalytical phase in the overall
quality of the total testing process in PHCs. The prev-
alence of haemolysed specimens has been suggested
as a suitable marker for preanalytical quality (12).
Most previous studies have used subjective visual
assessment (6–8, 13–15) or the analysis of free hae-
moglobin with laborious manual spectrophotometric
techniques (14, 16–18) to evaluate the prevalence of
haemolysis. The haemolysis index (HI) in automated
analysers is a more efficient method for detecting
haemolysis. For many years now, the HI has been
used in laboratories to automatically reject samples
that are haemolysed in order to avoid analytical inter-
ference. However, the possible use of all samples
with detectable HI as a marker of the overall preana-
lytical quality of the blood sample has not been
reported previously.
The aim was to use HI as an automated determinant
of haemolysis in venous blood samples sent from
PHCs to the routine laboratory. We investigated the
effect of different health care units, age and gender
on the prevalence of haemolysis.
Materials and methods
Subjects and setting
The clinical chemistry laboratory in this study was located
at a university hospital. The samples investigated were
received from the neighbouring PHCs (ns14) and nursing
homes (ns12), and the emergency department (ED) located
in the university hospital.
The majority of samples from the PHCs were collected by
enrolled nurses and, to a lesser extent, by registered nurses.
The nursing homes were staffed with enrolled and registered
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Table 1 Absolute number (n) and percentage (%) of test tubes with haemolysis index (HI) G15 in the units we investigated.
Included is the 95th percentile of the HI value.
Primary health care centres n HI G15, % HI 95th
Total 8849 10.4a 19
Men 3755 11.9b 20
Women 5094 9.3 19
Below median age (-63 years) 4629 9.2c 19
Above median age (G63 years) 4220 11.8 20
Nursing homes
Total 208 12.5 23
Men 75 14.7 22
Women 133 11.3 26
Below median age (-84 years) 114 14.0 24
Above median age (G84 years) 94 10.6 22
Emergency department
Total 447 31.1a 49
Men 232 33.2 67
Women 215 28.8 45
Below median age (-54 years) 230 30.0 62
Above median age (G54 years) 217 32.3 48
All units
Total 9504 11.4 21
Men 4062 13.1b 21
Women 5442 10.1 20
Below median age (-63 years) 4939 10.5d 21
Above median age (G63 years) 4565 12.4 21
p-Values estimated with x2-test. Significant difference between; aprimary health care centres and the emergency department,
p-0.001; bmen and women, p-0.001; cbelow or above the median age, p-0.001; dbelow or above the median age, p-0.004.
nurses, and blood collection was performed by both staff
categories. We compared two of the sections from the ED;
the first staffed by emergency medicine physicians and
the second staffed by PHC physicians. The latter handled
patients with less critical conditions. The ED blood collection
staff (registered and enrolled nurses) manned both sections
on a rotating schedule. The distribution of blood collection
staff in the investigated units is typical for Sweden. The
laboratory manual was identical for all units investigated.
Sample collection and measurements
Routine venous blood samples were collected by use of a
needle (and also by intravenous catheters in the ED) into
plastic 3.5 mL evacuated serum separator test tubes with an
inert polymer gel barrier and a clot activator (Becton Dick-
inson, Franklin Lakes, NJ, USA, cat-no 367957). After allow-
ing the sample to clotting for 30 min, the samples were
centrifuged locally or in the laboratory, and then analysed
for routine clinical chemistry analytes using a Vitros 5,1 auto-
mated analyser (Ortho-Clinical Diagnostics, Inc., Rochester,
NY, USA). This analyser automatically measured HI using a
spectrophotometric technique (19) in all blood samples. HI
for the Vitros 5,1 was evaluated by serial dilution of a puri-
fied haemolysate into two serum samples with a low degree
of haemolysis. The amount of free haemoglobin in these
samples was measured using a spectrophotometric assay
(20). There was a linear relationship between HI and the
amount of free haemoglobin (R2s0.9865), and 1 g/L of hae-
moglobin corresponded to a HI of 99. The samples were con-
sidered haemolysed at an HI G15 (equivalent to 0.15 g/L of
free haemoglobin). This level was the lowest detectable val-
ue, and was chosen to compare the total amount of hae-
molysed samples from the units we investigated.
Data collection
We performed a retrospective study on samples (ns9504)
sent from PHCs, nursing homes and the university hospital
ED to the clinical chemistry laboratory for analysis on the
Vitros 5,1 analyser (Table 1). Three identical analysers were
used on a rotating schedule. HI values and the laboratory
identification number (LID) were obtained from the analysers
for samples analysed during the study period (May to Sep-
tember 2008). Information on age and gender of the patients
along with the ordering unit was obtained from the labora-
tory information system (Flexlab 2.2.2, TietoEnator, Kista,
Sweden).
The PHCs were divided according to their distance from
the laboratory. Group one included eight PHCs with distanc-
es ranging from 1 to 8 km from the laboratory, and group
two was comprised of the other six PHCs (distances ranging
from 17 to 86 km). Test tubes were collected in cooled insu-
lated transport boxes (5–128C). They were collected twice a
day from the PHCs close to the laboratory, and once a day
from the more remote PHCs.
Statistical analysis
Data from the analysers and the laboratory information sys-
tem were merged using the corresponding LID for each anal-
ysis. The complete file contained the analysis, the HI value,
the ordering unit, and age and gender of the patient. Dupli-
cate LIDs were excluded (i.e., samples where more than one
analysis had been performed) resulting in a file containing
one LID for each test tube. Cases with missing HI due to
machine error (ns191), or cases where invalid patient iden-
tification prohibited determination of patient age and gender
(ns5) were excluded. SPSS 14.0 for Windows (SPSS Inc.,
Chicago, IL, USA) was used for all statistical analyses. Cat-
egorical variables were compared using the x2-test. Multi-
variate logistic regression analysis was used to study how
different units, gender and age simultaneously affected the
likelihood of samples having a HI G15. To measure associ-
ation, odds ratios (OR) and their corresponding 95% confi-
dence intervals (CI) were used. The significance level was set
at p-0.05. The research plan was approved by the Regional
Ethical Review Board (D-No 07-13M).
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Results
Baseline characteristics are presented in Table 1. Of
the 8849 test tubes that were analysed from the PHCs,
10.4% had a HI G15 with a 95th percentile of 19. For
samples sent from the PHCs, haemolysed samples (HI
G15) were more common among men (11.9%) than
among women (9.3%) (p-0.001). Haemolysed sam-
ples also occurred more frequently in patients above
the median age than below the median age (11.8%
vs. 9.2%) (p-0.001). Univariate analysis showed that
for the PHCs investigated, samples collected from
men were haemolysed 1.3 times (95% CI 1.1–1.5) as
often compared to samples collected from women.
Further, samples collected from patients above the
median age (63 years) were haemolysed 1.2 times
(95% CI 1.1–1.4) more often compared to samples
from patients below the median age. There was no
significant difference in the prevalence of haemolysed
samples with respect to age or gender in nursing
homes or in the ED. The PHCs had fewer haemolysed
samples compared to samples sent from the ED
(10.4% vs. 31.1%, p-0.001). There was no significant
difference in haemolysed samples between the PHCs
and the nursing homes.
Multivariate associations are presented in Table 2.
Major differences in the prevalence of haemolysed
samples existed between the different PHCs. Samples
collected in the PHC with the highest prevalence of
haemolysed samples were 6.1 times (95% CI 4.0–9.2)
more often haemolysed compared to the centre with
the lowest prevalence. Further, PHCs located outside
the urban area (more than 17 km from the laboratory)
were haemolysed 1.7 times (95% CI 1.5–2.0) more
often compared to the PHCs close to the laboratory.
A notable difference in haemolysed samples were
found between the ED section staffed by emergency
medicine physicians (34.8%), and the section staffed
by PHC physicians (11.3%, x2-test: p-0.001). Samples
collected in the emergency medicine physician sec-
tion of the ED were haemolysed 4.3 times (95% CI
2.0–9.4) more often compared to samples collected in
the PHC physician section. There was no significant
difference in the prevalence of haemolysed samples
between the ED section staffed with PHC physicians
and the PHCs (data not shown).
Rejection levels and percentage of possible rejected
samples are presented in Table 3. Of the samples
from the PHCs that were investigated, 3.1% had a HI
value above 25 and 0.8% had an HI value above 50.
In the ED, the HI value exceeded 25 in one out of six
samples (16.1%), and exceeded 50 in 5.1% of all sam-
ples. These are levels at which the results of several
routine assays would be rejected.
Discussion
The results of this study indicate that there is a sig-
nificant variation in the prevalence of haemolysed
samples among PHCs. Most cases of haemolysis in
blood specimens are caused by mistakes in the col-
lection and handling of the sample (1). The demon-
strated differences between different PHCs were
adjusted for age and gender. Thus, the differences
are likely to be a reflection of varying preanalytical
conditions, rather than variation in these patient
characteristics. The higher prevalence of haemolysis
in samples collected outside the urban area likely
reflects differences in the collection and handling of
the sample before centrifugation.
Samples from patients over the median age were
associated with a higher prevalence of haemolysis
in the PHCs. This finding is in contrast to a previous
hospital report (21) where no age related differences
in haemolysis were found. Difficulties in accessing
veins, or repeated attempts at venipuncture, can
cause haemolysis (15). Such difficulties can also lead
to collection of blood from sites other than the pre-
ferred antecubital veins, resulting in haemolysis (6,
13, 21). Therefore, one possible explanation for the
association between age and HI is due to greater dif-
ficulties in obtaining venous access in the elderly. We
have no explanation for the differences the incidence
of haemolysed specimens between men and women.
There was no difference in haemolysed samples
between PHCs and nursing homes, suggesting similar
preanalytical conditions. In line with previous find-
ings, the ED stood out as a major contributor of hae-
molysed samples (6, 22). In addition, the ED section
staffed with emergency medicine physicians had a
higher prevalence of haemolysed samples when
compared with the ED section staffed with PHC
physicians. These results were independent of age
and gender. The most probable explanation is a more
common use of intravenous catheters for collection
of blood samples in the emergency medicine section
of the ED, a practice known to cause haemolysis (7,
8, 15). Since the blood collection staff manned both
sections, the differences seem less likely to depend
on the skills and experience of the staff, which pre-
viously has been shown to affect specimen quality
(23).
In vitro haemolysis is a major cause of rejection of
specimens in laboratories (2). Specimen rejection is
costly and repeat sampling is stressful for patients
(24). Haemolysis can cause prolonged turn around
time for the tests that are ordered. This could affect
patient workflow and be harmful to critically ill
patients (25). Further, undetected haemolysis can
increase or decrease the values for several analytes
(17, 18, 26) leading to clinically significant alterations
of, for example, potassium and lactate dehydrogen-
ase (18). In fact, mild haemolysis, almost undetectable
by visual inspection, is known to influence test results
(18). In our study, more than 10% of all specimens,
and 31% of the specimens from the ED, suffered from
some degree of haemolysis. This is a higher percent-
age than previously reported for all samples
(2.6%–3.3%) and ED samples (12.4%–18.1%) (6, 8, 16,
22). This difference could be due to the low detec-
tion limit for haemolysis used in this study. Subjec-
tive visual inspection, used in many of the previous
reports, can be unreliable in the assessment of sam-
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Table 2 Absolute number (n) and percentage (%) of test tubes with haemolysis index (HI) G15 in the units investigated. The
data are shown as multivariate models with odds ratios (OR) and confidence intervals (CI).
Unita n HI G15% HI G15 OR (95% CI) p-Value
Primary health care centres 8849 10.4 1.0
Nursing homes 208 12.5 1.13 (0.74–1.73) 0.560
Emergency department 447 31.1 3.93 (3.17–4.86) -0.001
Primary health care centresa
1 574 6.6 1.0
2 963 6.6 1.00 (0.66–1.52) 0.999
3 492 6.7 1.01 (0.63–1.64) 0.956
4 443 6.8 0.97 (0.59–1.60) 0.916
5 598 8.4 1.22 (0.79–1.90) 0.368
6 1096 8.5 1.28 (0.87–1.90) 0.211
7 731 8.6 1.39 (0.91–2.11) 0.128
8 1425 9.1 1.40 (0.96–2.04) 0.079
9 622 12.4 2.04 (1.36–3.07) 0.001
10 484 14.9 2.44 (1.61–3.69) -0.001
11 790 15.8 2.53 (1.73–3.71) -0.001
12 25 16.0 2.71 (0.88–8.30) 0.082
13 333 16.8 2.80 (1.81–4.34) -0.001
14 273 31.9 6.06 (3.99–9.21) -0.001
Nursing homesa
1 37 2.7 1.0
2 16 6.3 2.42 (0.14–41.76) 0.544
3 14 7.1 3.65 (0.21–64.90) 0.378
4 23 8.7 3.66 (0.30–44.02) 0.307
5 28 10.7 5.84 (0.55–62.50) 0.144
6 16 11.8 5.53 (0.46–67.20) 0.179
7 20 15.0 6.49 (0.59–71.70) 0.127
8 5 20.0 10.51 (0.53–209.7) 0.124
9 5 20.0 8.20 (0.41–164.1) 0.169
10 8 25.0 17.05 (1.25–232.6) 0.033
11 35 25.7 16.30 (1.86–142.9) 0.012
12 1 100.0 0.00 (0.00–0.00) 1.000
Emergency department sectionsa
Staffed with primary health care 71 11.3 1.0
physicians
Staffed with emergency medicine 376 34.8 4.32 (1.99–9.38) -0.001
physicians
Distance to the laboratorya
8 PHCs close to the 5903 8.4 1.0
laboratory (1–8 km)
6 PHCs far from the 2921 14.4 1.74 (1.51–2.00) -0.001
laboratory (17–86 km)
aORs adjusted for age and gender. PHC, primary health care centre.
Table 3 Percentage (%) of potentially rejected samples at the units investigated based on haemolysis index (HI) levels for
specimen rejection according to Ortho-Clinical Diagnostics and the definition of mild haemolysis ()0.6 g/L) according to Lippi
et al. (1).
Unit Percentage (%) of rejected samples
HI G25a (0.25 g/L)c HI G50b (0.5 g/L)c HI G60 (0.6 g/L)c
Primary health care centres 3.1 0.8 0.6
Nursing homes 4.8 1.4 0.4
Emergency department 16.1 5.1 4.6
All units 3.7 1.0 0.8
Rejection levels for: aHaptoglobin; broutine assays including potassium, aspartate aminotransferase, alanine aminotransferase,
alkaline phosphatase, iron, magnesium, lactate dehydrogenase, phosphate; ccorresponding levels of free haemoglobin.
ple haemolysis (27) when compared to the HI, used
in this study (28).
To our knowledge, this is the first study to survey
HI in blood samples sent from PHCs, and to compare
the HI with respect to type of unit. This study is also
the first to assess the use of HI as a marker of the
overall preanalytical quality of the blood sample.
Using the lowest detectable HI level, we could study
the total number of samples with haemolysis from the
units we investigated, making it useful as a sensitive
marker for preanalytical quality. This HI level (G15) is
not intended to be used for sample rejection due to
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haemolysis. It must be noted that this level is lower
than the cut-offs for rejection of each analyte based
on HI levels set by the manufacturer.
The number of samples we investigated was high.
The blood collection staff was representative for the
respective setting in Sweden, and comparable to
other blood collection staff categories internationally.
Future studies are needed to investigate the influence
of specific preanalytical practices on HI. A practical
value of this use of the HI is to implement the correct
quality interventions of all aspects of the preanalytical
phase. It also allows the possibility for follow-up of
such interventions.
In conclusion, the significant variation in HI among
the investigated units is likely to reflect varying
preanalytical conditions. Therefore, monitoring of
haemolysis indices is a valuable tool for estimating
preanalytical quality in primary health care.
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